The Bioss Blog

News, updates, and analysis from the world of research. Interested in having your work with Bioss' products featured on the site? Email marketing@biossusa.com for more information.

Be sure to follow us on Twitter and Facebook for regular updates.

Protective Antibodies Against COVID-19 Isolated & Characterized

In the search for interventions against COVID-19, one potential mode of intervention would be to block viral entry into target cells by blocking the interaction between the receptor-binding domain (RBD) of the spike protein of SARS-CoV-2 and thefalse

COVID-19 Antibody Testing

The first wave of Covid-19 tests is designed to determine whether you have the SARS-CoV-2 virus right now. As the world starts to eye an exit from lockdown, the second wave of tests is trying to find out if you had the virus in the past. To thisfalse

Newly discovered coronavirus mutations warn vaccine developers

 New research in China found 31 mutations in the genetic code of the coronavirus within 11 coronavirus patients. Nineteen of the mutations in COVID-19 were novel, meaning they had not been seen before. Researchers then infected live, non-humanfalse

COVID-19 Vaccines being Tested in Clinical Trials

The coronavirus juggernaut continues to travel across the globe. For now, we are relying on tools such as physical distancing to control the spread of the virus, but in the long term a COVID-19 vaccine may be our best hope for a return to normalfalse

Self-diagnosis for COVID-19

The novel coronavirus has infected almost one million people and killed tens of thousands on nearly every continent. Even with offices shut down, people staying at home and hospitals bracing for an influx of patients, the pandemic continues itsfalse

A brief overview of COVID-19 diagnostic tests

COVID-19 is the infectious disease caused by a novel coronavirus, which was first identified by Chinese authorities and provisionally named as 2019-nCoV. The International Committee on Taxonomy of Viruses gave the official name SARS-COV-2 to thefalse

Newly Announced Epitopes of SARS-CoV-2 May Facilitate the Vaccine Design

AMERICAN SCIENTISTS IDENTIFY POTENTIAL TARGETS FOR IMMUNE RESPONSES TO NOVEL CORONAVIRUS

1 2 3 4 5